hoodb.com

漢達(6620)代子公司Handa Oncology, LLC公告505(b)(2)新藥Vysentri HND-033向美國FDA申請展延CRL補件期限12個月(10/17日股價65.8元)

|

You are leaving and open the following URL" of about "a 臨床試驗申請(12" news

news.google.com/rss/articles/CBMickFVX3lxTE8xekdXX3RvU1RiZGQ0c2J5dlM4di0yUGJ2SWRoVjcwX0RvQ29WMXhLTzBTVUlqVm1rOVF6Tk51R05ReTEtOUJCWWdydUxWWHNDOVg2MTZtRURTMUtZTmk4QlBuaXRrMlAxaDFxQ0ZCbmRodw?oc=5


Continue Opne >

a 臨床試驗申請(12: 漢達(6620)代子公司Handa Oncology, LLC公告505(b)(2)新藥Vysentri HND-033向美國FDA申請展延CRL補件期限12個月(10/17日股價65.8元)


More a 臨床試驗申請(12 news:



Warning: filemtime(): stat failed for aCache/aaa/gnews/AR/a 臨床試驗申請(12.xml in /var/www/hoodb/function.php on line 339
1736655859-
Warning: file_put_contents(aCache/aaa/gnews/AR//a 臨床試驗申請(12.xml): Failed to open stream: No space left on device in /var/www/hoodb/function.php on line 348

About a 臨床試驗申請(12

from
1736655860-1736281028

Warning: filemtime(): stat failed for aCache/search/ar/a 臨床試驗申請(12 in /var/www/hoodb/function.php on line 339
1736655860-

a 臨床試驗申請(12, 漢達(6620)代子公司Handa Oncology, LLC公告505(b)(2)新藥Vysentri HND-033向美國FDA申請展延CRL補件期限12個月(10/17日股價65.8元) 2022 a 臨床試驗申請(12

漢達(6620)代子公司Handa Oncology, LLC公告505(b)(2)新藥Vysentri HND-033向美國FDA申請展延CRL補件期限12個月(10/17日股價65.8元)

Choose Your Country or Region


Back to Top



漢達(6620)代子公司Handa Oncology, LLC公告505(b)(2)新藥Vysentri HND-033向美國FDA申請展延CRL補件期限12個月(10/17日股價65.8元)

Copyright © 2020-2021 hoodb.com. All Rights Reserved.